Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

Smart Immune to Present ReSet-02 Phase I Preliminary Data and the Determination of the Recommended Dose at ASH 2024

November 5, 2024

Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials

October 23, 2024

Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial

May 2, 2024

Smart Immune appoints key new members to its Board of Directors

February 16, 2024

Rahim Fandi, M.D, PhD, joins Smart Immune as Chief Medical Officer

December 4, 2023

Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform

November 10, 2023